Protagen and Charles River Laboratories International have formed a strategic marketing & sales alliance.

For Charles River the fast-growing demand for biopharmaceuticals testing requires an expert partner with a broad range of services. Charles River delivers client-focused solutions tailored to the specific testing and manufacturing requirements of biologics. Partnering with Protagen, a specialist in the fields of in-vitro diagnostics and GMP-compliant protein analysis, will provide clients with services covering the entire range of protein analytics from detailed protein characterization to stability and lot release testing.

Working together, Charles River and Protagen can offer analytical experience and superior services through a single point of contact, providing more efficient project work and study design.

“The technology portfolio and the exceptional expertise of Charles River in the area of certified bioservices will synergistically complement the experience and competences of Protagen in the field of biotherapeutics and biosimilars. The customers in the pharmaceutical and biotech sector will profit from this alliance through the direct access to a comprehensive service portfolio,” said Dr. Stefan Müllner, CEO of Protagen.